Table of contents

  • Preliminary material
    • Title and verso pages
    • Contents
    • Acknowledgments
    • Summary
      • Prevalence of treated-ESKD is increasing
      • Diabetes to continue to contribute to increases in treated-ESKD
      • Dialysis- and transplant-treated-ESKD cases are projected to increase
  • Body section
    • 1 Introduction
    • 2 Methods
      • Data sources
      • Construction of 'base' prevalence projections model
      • Projection assumptions
      • Variables controlled for in 'base' prevalence projections model
      • Data limitations
      • Alternative models
    • 3 Base prevalence projections model
      • Overall
      • Kidney replacement therapy (KRT) treatment trends
      • Influence of diabetes
    • 4 Alternative models
      • 'Stable incidence' model
      • 'Improving dialysis treatment outcomes' model
    • 5 Discussion
      • Implications of projections
      • The issue of untreated-ESKD
      • Future projections work
  • End matter
    • Appendixes
      • Appendix A: Treatment options for end-stage kidney disease (ESKD)
        • Kidney replacement therapy (KRT)
        • Non-KRT treated-ESKD
      • Appendix B - Statistical methods
        • Time-series analysis
        • Prevalence model construction
        • Estimating the incidence of dialysis-treated- and transplant-treated-ESKD
        • Follow-up of projected incident cases and existing prevalent patients
      • Appendix C - Model accuracy
        • Incidence model accuracy
        • Follow-up of patients over the projection period
      • Appendix D - Alternative models
        • 'Stable incidence' model
        • 'Improving dialysis treatment outcomes' model
      • Appendix E - Detailed data
        • Existing treated-ESKD incidence trends
        • Incidence projection results
        • Prevalence projection results
    • Glossary
    • References
    • List of tables
    • List of figures